To include your compound in the COVID-19 Resource Center, submit it here.

EC approves updated Tysabri label

The European Commission approved an updated label for autoimmune drug Tysabri natalizumab from Biogen Idec Inc.

Read the full 165 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE